Operator
Good day, ladies and gentlemen. And welcome to the Avid Bioservices Third Quarter Fiscal 2021 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference may be recorded.
I would now turn the call over to Mr. Tim Brons of Avid s Investor Relations Group. Please go ahead, sir.
Tim Brons
Investor Relations
Thank you. Good afternoon and thank you for joining us. On today s call, we have Nick Green, President and CEO; Dan Hart, Chief Financial Officer; and Timothy Compton, Chief Commercial Officer.
Today, we will be providing an overview of Avid Bioservices contract development and manufacturing business, including updates on corporate activities and financial results for the quarter ended January 31, 2021. After our prepared remarks, we will welcome your questions.
Operator
Welcome to the Lannett Company s Fiscal 2021 Second Quarter Financial Results Conference Call. My name is Adrian. I will be your operator for today s call. [Operator Instructions] Please note that this conference is being recorded.
I will now turn the call over to Robert Jaffe. Robert Jaffe, you may begin.
Robert Jaffe
Good afternoon, everyone. And thank you for joining us today to discuss Lannett Company s fiscal 2021 second quarter financial results. On the call today are Tim Crew, Chief Executive Officer; and John Kozlowski, the company s Chief Financial Officer; and Maureen Cavanaugh, our Chief Commercial Operations Officer. This call is being broadcast live at www.lannett.com. A playback will be available for at least three months on Lannett s website.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Ligand Pharmaceuticals Q4 Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Patrick O Brien. Thank you. Please go ahead.
Patrick O Brien
Investor Relations
Thank you, Brandy. And welcome to Ligand s fourth quarter of 2020 financial results and business update conference call. All of our speakers for today s call are in separate locations. Speaking today for Ligand will be John Higgins, CEO; Matt Foehr, COO; and Matt Korenberg, CFO. We will use non-GAAP financial measures and some of our statements will be forward-looking. Additional information concerning risk factors and other matters concerning Ligand can be found in our Ligand s earning press release and our periodic filings with the SEC. Ligand undertakes no obligation to revise or update any statements to reflect events or circumstances after the date of this conference call.
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Omnicell Fourth Quarter Earnings Conference Call. [Operator Instructions]
I would now like to hand the conference over to your speaker today, Ms. Kathleen Nemeth. Thank you. Please go ahead.
Kathleen Nemeth
Vice President, Investor Relations
Thank you, operator. Good afternoon and welcome to the Omnicell fourth quarter and full year 2020 financial results call. On the call with me today are Randall Lipps, Omnicell s Founder, Chairman, President and CEO; Scott Seidelmann, Executive Vice President and Chief Commercial Officer; and Peter Kuipers, Executive Vice President and Chief Financial Officer.